Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Dietary Supplements

Pink Pussycat Sensual Enhancement Capsules Recalled for Undeclared Sildenafil

Agency Publication Date: April 18, 2022
Share:
Sign in to monitor this recall

Summary

Pink Toyz is recalling 120 blister cards of Pink Pussycat Sensual Enhancement Capsules (3000mg) because they contain sildenafil, an undeclared drug ingredient. Sildenafil is the active ingredient in FDA-approved prescription drugs for male sexual enhancement, making these capsules unapproved drugs when sold as supplements. The product was sold nationwide in the United States through the walmart.com online marketplace. No incidents or injuries have been reported to date.

Risk

Undeclared sildenafil can interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease are particularly at risk as they frequently take nitrate-containing medications.

What You Should Do

  1. The recalled products are 1-count blister cards of Pink Pussycat Sensual Enhancement capsules (3000mg) with UPC 891875004626.
  2. Identify the affected products by checking for lot number 2009066 and an expiration date of 09/2023 on the packaging.
  3. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls for more information.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Pink Pussycat SENSUAL ENHANCEMENT capsule (3000mg)
Variants: 1-count blister card
UPC Codes:
891875004626
Lot Numbers:
2009066 (Exp 09/2023)

Manufactured for: Pink Pussycat Products - Chatsworth, CA 91311

Product Images

Image 2 - Package Back โ€“ PINK PUSSYCAT

Image 2 - Package Back โ€“ PINK PUSSYCAT

Labeling, Pink Pussycat, front of package

Labeling, Pink Pussycat, front of package

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 89949
Status: Resolved
Manufacturer: Pink Toyz
Sold By: walmart.com
Manufactured In: United States
Units Affected: 120 blister cards
Distributed To: Nationwide
Agency Last Updated: April 25, 2022

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท FDA Press Release (1) ยท FDA Press Release (2) ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.